DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-73.39%
US · US
TMUS.US latest organized financial period shows revenue lacks a complete YoY comparison and net income declined -3.06% YoY. Current price is about 196 USD, while the model base case is about 121 USD; the current price sits +61.6% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:23
Hover each model row to inspect formulas and inputs.
+61.56%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-73.39%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+75.2%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -1.4% annualized FCF growth.
Estimates earnings power value without assuming growth.
+49.9%
Updated: 2026/04/29 15:23
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -220M USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -75M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -532M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -1B USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -3B USD | Medium |
| 2021/12/31 | Restructuring charges | Restructuring | -510M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -991M USD | Medium |
| 2020/12/31 | Discontinued operations | Discontinued operations | 960M USD | High |
| 2020/12/31 | Restructuring charges | Restructuring | -3B USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -439M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | - | 11B USD | 11B USD | 18B USD | 9.72 | 9.91 |
| 2024/12/31 | Annual | - | 11B USD | 11B USD | 13B USD | 9.66 | 9.72 |
| 2023/12/31 | Annual | - | 8B USD | 9B USD | 9B USD | 6.93 | 7.37 |
| 2022/12/31 | Annual | - | 3B USD | 7B USD | 3B USD | 2.06 | 5.21 |
| 2021/12/31 | Annual | - | 3B USD | 4B USD | 2B USD | 2.41 | 2.82 |
Profit after costs, expenses, interest, and taxes.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.